← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Rasburicase currently has availability issues reported in 2 European registers: Germany, Ireland.
Shortage ATC V03AF07 · also listed as: Rasburicase · data refreshed 21 September 2026
As of 21 September 2026, 2 of the 8 tracked registers list current availability issues for Rasburicase, covering 2 affected product presentations. The longest-running open report was filed in Ireland on 2026-05-18 and has now been open for about 4 months. Where agencies state a cause, quality issues lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-10-21; the earliest is 2026-10-21. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Registers in Germany, Ireland indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Rasburicase is coded V03AF07 — a medicine acting on various — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇪🇺 EU-wide (EMA) | Resolved Fasturtec (rasburicase) | 2023-03-31 | — | Hyperuricemia | register ↗ |
| 🇩🇪 Germany | Shortage Fasturtec 1,5 mg Pulver und Lösungsmittel zur Herstellung eines Infusionslösungskonzentrats - OP(3+3) | 2026-09-29 | 2026-10-21 | Sonstige Alternatives: N/A | register ↗ |
| 🇮🇪 Ireland | Shortage Fasturtec 1.5 mg / ml powder and solvent for concentrate for solution fo | 2026-05-18 | 2026-06-10 | Quality issue (Multiple countries) Alternatives: No authorised alternative listed. | register ↗ |
Every individual register entry for Rasburicase in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇩🇪 DE | Fasturtec 1,5 mg Pulver und Lösungsmittel zur Herstellung eines Infusi | Shortage | 2026-09-29 | 2026-10-21 | Sonstige |
| 🇮🇪 IE | Fasturtec 1.5 mg / ml powder and solvent for concentrate for solution | Shortage | 2026-05-18 | 2026-06-10 | Quality issue (Multiple countries) |
| 🇪🇺 EU | Fasturtec (rasburicase) | Resolved | 2023-03-31 | — | Hyperuricemia |
Yes. As of 21 September 2026, availability issues are reported in: Germany, Ireland. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-10-21 to 2026-10-21. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Rasburicase: BfArM (Germany), EMA shortages catalogue (EU), HPRA (Ireland). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Rasburicase — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rasburicase/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Rasburicase availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rasburicase/">Rasburicase shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>